Immunolocalization of HIV envelope gp120 in HIV encephalitis with dementia.
about
Signalling crosstalk in FGF2-mediated protection of endothelial cells from HIV-gp120HIV envelope induces a cascade of cell signals in non-proliferating target cells that favor virus replicationApoptosis of uninfected cells induced by HIV envelope glycoproteinsBlood-brain barrier and retroviral infectionsApoptotic death of striatal neurons induced by human immunodeficiency virus-1 Tat and gp120: Differential involvement of caspase-3 and endonuclease GHIV-1 gp120 induces cytokine expression, leukocyte adhesion, and transmigration across the blood-brain barrier: modulatory effects of STAT1 signalingNeonatal intrahippocampal HIV-1 protein Tat(1-86) injection: neurobehavioral alterations in the absence of increased inflammatory cytokine activation.Neonatal intrahippocampal gp120 injection: an examination early in development.Neonatal intrahippocampal injection of the HIV-1 proteins gp120 and Tat: differential effects on behavior and the relationship to stereological hippocampal measuresPhosphatidylcholine-specific phospholipase C activation is required for CCR5-dependent, NF-kB-driven CCL2 secretion elicited in response to HIV-1 gp120 in human primary macrophages.Cardiomyocytes undergo apoptosis in human immunodeficiency virus cardiomyopathy through mitochondrion- and death receptor-controlled pathwaysFailure of HIV-exposed CD4+ T cells to activate dendritic cells is reversed by restoration of CD40/CD154 interactionsCB2 receptor agonists protect human dopaminergic neurons against damage from HIV-1 gp120.Chemokine CXCL8 promotes HIV-1 replication in human monocyte-derived macrophages and primary microglia via nuclear factor-κB pathway.Novel mechanisms of central nervous system damage in HIV infection.Human immunodeficiency virus-associated dementia: a link between accumulation of viral proteins and neuronal degeneration.HIV-1 proteins, Tat and gp120, target the developing dopamine systemHIV-1-driven regulatory T-cell accumulation in lymphoid tissues is associated with disease progression in HIV/AIDS.HIV-gp120 and physical dependence to buprenorphineMorphine efficacy is altered in conditional HIV-1 Tat transgenic mice.Essential role of p53 phosphorylation by p38 MAPK in apoptosis induction by the HIV-1 envelope.Neurotoxic profiles of HIV, psychostimulant drugs of abuse, and their concerted effect on the brain: current status of dopamine system vulnerability in NeuroAIDSExpression of CHRFAM7A and CHRNA7 in neuronal cells and postmortem brain of HIV-infected patients: considerations for HIV-associated neurocognitive disorderDopaminergic marker proteins in the substantia nigra of human immunodeficiency virus type 1-infected brains.Engagement of the CD4 receptor affects the redistribution of Lck to the immunological synapse in primary T cells: implications for T-cell activation during human immunodeficiency virus type 1 infection.Cannabinoids inhibit HIV-1 Gp120-mediated insults in brain microvascular endothelial cells.Differential long-term neurotoxicity of HIV-1 proteins in the rat hippocampal formation: a design-based stereological studyProliferation of Perivascular Macrophages Contributes to the Development of Encephalitic Lesions in HIV-Infected Humans and in SIV-Infected Macaques.Microglia: gatekeepers of central nervous system immunology.Dose-dependent long-term effects of Tat in the rat hippocampal formation: a design-based stereological study.CNS inflammation and macrophage/microglial biology associated with HIV-1 infection.Functional interaction between HIV-gp120 and opioid system in the preoptic anterior hypothalamusInteractions between prostaglandins, leukotrienes and HIV-1: possible implications for the central nervous system.HIV-1 gp120 compromises blood-brain barrier integrity and enhances monocyte migration across blood-brain barrier: implication for viral neuropathogenesis.Peroxisome proliferator-activated receptor-gamma: potential molecular therapeutic target for HIV-1-associated brain inflammation.Endocannabinoids exert CB1 receptor-mediated neuroprotective effects in models of neuronal damage induced by HIV-1 Tat protein.HIV-associated motor neuron disease: HERV-K activation and response to antiretroviral therapy.Rescue of adult hippocampal neurogenesis in a mouse model of HIV neurologic disease.Human blood-derived macrophages enhance barrier function of cultured primary bovine and human brain capillary endothelial cells.Dose-dependent neurocognitive deficits following postnatal day 10 HIV-1 viral protein exposure: Relationship to hippocampal anatomy parameters.
P2860
Q21262047-360E25AF-D88B-411D-AC47-05AA66220DD4Q24534883-58BFC5EF-6DC4-4AE3-893C-C756910CA55EQ24801374-5B11ED0F-2598-49EB-B4FA-40A36928E9CFQ26830903-BE5057D6-2CA1-45A9-AAB7-B64830C000AAQ28267535-58579602-6863-4193-8A22-FA74DC1E4930Q28304859-C7862B27-DC41-4B23-8D9B-158CEB137155Q30399828-584A3EE8-E1D0-4240-AD6E-C28A35C365A7Q30452600-8F94B3CD-E2AF-4E85-8D08-7FE9106EAE0DQ30486458-00361033-71C2-477A-A2CB-5AE7F4645823Q33315307-2C50710B-895D-41AB-B3E5-4E069C2AA4D4Q34393925-D6EA9B3A-5562-412C-86B4-E792986EA77CQ34396833-48C4AB00-E199-4B43-8C36-F70ABCFA3E73Q35023230-1F7C8B45-E9B7-401E-ACF0-7E4003880F22Q35129108-0C17CE4D-5962-4E91-A921-CF287FCBF487Q35557261-58522F3D-904F-4CB8-9A7D-9C173AACB073Q35702700-45EE113B-6FC3-4927-AAF7-E620D658714FQ35743630-46923781-E851-4FB6-8A51-F960DF5D9F91Q35848896-F406A5A6-0453-4B60-8270-41CA07A2DA4AQ36069676-F1D3A9EE-0AAF-45DC-926E-55EBD1C1CE23Q36109980-52D200B6-9D50-4C5F-A776-70D535373DF1Q36402588-26DC1388-3D29-4BE0-BEFE-9CAC4149FF94Q36856162-F43A6E2A-BA0C-454A-8EB5-2C74C7ECC3F7Q36900932-5A506896-D0CA-404D-B366-980A2370EE25Q37009432-C5508E6E-8779-48BF-A478-397090EA42E8Q37051575-65645B65-58DA-4754-A0C3-7235F4EE09E4Q37074777-CE463FFB-6EFE-4DFC-8D2E-D4412D35BD89Q37092361-8E1CBF13-AAA5-4E7A-992F-F3C00D2A3257Q37244320-1BBBCF7D-8D5A-4717-8558-544DA371DFEFQ37333298-9500B33C-4F78-4E47-9D4E-56D11E63D37CQ37344253-0BA42693-8669-45A4-873A-234D7848379CQ37600700-0D5BDE5C-8E43-41C9-AEDF-FCF76FB51BCBQ37682570-3C4D4FDF-77F0-4D94-B4FB-523FD0AF3620Q37974980-D757D642-6BAC-4CEE-BEF6-FEDFDAC6638AQ39119645-C2AF80EA-F21E-4EEC-9F1D-F11A7AE5CD29Q40050469-C2258C9D-A0B4-46A2-B156-3FBD69E43E90Q40112882-C6D63BCF-F463-49F3-BDE4-3E7E9DD2085BQ40488059-BD3E05AC-3382-43B9-AA18-E809A1F1DA67Q41950909-585F8AF5-A38B-4578-B5E6-6E8973125EB3Q44493503-95891BB3-D868-401E-ADE5-522DEFE40694Q47432196-987AB329-054B-4834-A1BD-3AA86D3C5AC8
P2860
Immunolocalization of HIV envelope gp120 in HIV encephalitis with dementia.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh-hant
name
Immunolocalization of HIV envelope gp120 in HIV encephalitis with dementia.
@en
Immunolocalization of HIV envelope gp120 in HIV encephalitis with dementia.
@nl
type
label
Immunolocalization of HIV envelope gp120 in HIV encephalitis with dementia.
@en
Immunolocalization of HIV envelope gp120 in HIV encephalitis with dementia.
@nl
prefLabel
Immunolocalization of HIV envelope gp120 in HIV encephalitis with dementia.
@en
Immunolocalization of HIV envelope gp120 in HIV encephalitis with dementia.
@nl
P2093
P1433
P1476
Immunolocalization of HIV envelope gp120 in HIV encephalitis with dementia.
@en
P2093
P304
P356
10.1097/00002030-200012010-00010
P407
P577
2000-12-01T00:00:00Z